This was an interesting interview with Richard Saynor, the head of Sandoz (which is now an independent generics company). That’s a part of the industry

(MedPage Today) — Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in real-world settings versus what is

I’ve done plenty of DNA tests to help me explore my heritage a little deeper (I’m a hodgepodge of Eastern European, in case you’re wondering).

Teens are being prescribed Ozempic and similar drugs more than ever before — and some doctors are worried about what the trend could mean. In

A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight loss in a real-world setting because

(MedPage Today) — CHICAGO — Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse events tied to blockbuster

The popularity of glucagon-like peptide-1 (GLP-1) receptor agonists continues, with use of tirzepatide and semaglutide surpassing that of traditional weight-lowering medications.

Amplifye, a UC Davis spinout led by former Amyris CEO John Melo, has launched its first product: a proprietary enzyme (P24) claimed to optimize protein

In 2024, the cost and utilization of specialty dermatology drugs significantly drove a 7% increase in pharmaceutical costs, according to a June 10 report from

Metsera’s drug shows potential in early clinical trial  statnews.com Weight-loss newbie Metsera says once-monthly amylin matches GLP-1 efficacy  FirstWord Pharma Obesity Startup Metsera Shares Rise on Early-Stage

DALLAS–(BUSINESS WIRE)–Pharmaceutical Strategies Group (“PSG”), an EPIC company, published its 2025 Trends in Drug Benefit Design Report, delivering critical insights into how payers are navigating

Lembas is a new b2b ingredient business that makes a peptide powder that targets the GLP-1 hormone for weight loss

Weight-loss drugs continue to grow in popularity, with market researchers predicting that global demand for the medications could reach $150 billion by 2035. GLP-1 agonists

New findings about semaglutide and tirzepatide use from health records suggest lower overall weight loss but also factors that predict success. Medscape Medical News

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight loss in a real-world setting because patients discontinue treatment or

A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups. Originally developed for diabetes,

National Resilience, a startup that has raised over $2 billion by promising to transform drug manufacturing, said Monday that it would “wind down” many of

WEIGHT loss jabs could prevent a medication taken by millions of women from working – and increase patients’ risk of cancer. The British Menopause Society

Metsera has linked its amylin analog to 8.4% placebo-adjusted weight loss at Day 36, advancing its push to develop an ultralong-acting challenger to candidates in

GLP-1 drugs “alter taste perception” and “disrupt the perception of sweetness, bitterness, fatty foods and even mouthfeel”, a study says. The post GLP-1 drugs “alter

GLP-1 drugs “alter taste perception” and “disrupt the perception of sweetness, bitterness, fatty foods and even mouthfeel”, a study says.

GLP-1 drugs are transforming medicine, but what are the medical and societal ripple effects?

Politics Most Favored Nation Drug Pricing Will Flop, but What Wouldn’t? Pursuing the worthy goal of reforming drug pricing requires a more radical change to

The 71-year-old OWN CEO finally reached her 160lb goal weight in 2023 with help from an unnamed GLP-1 agonist drug after undergoing double-knee replacement surgery

Will a telehealth model effectively engage adolescents with obesity and their parents to participate in their treatment plan? Do GLP-1 agonist medications work to improve

We’ve known that our immune system and the process of inflammation are tightly intertwined and are affected by aging. The terms immunosenescence and inflammaging have

Obesity is a major health problem facing our country.  According to the CDC, more than 40 percent of the U.S. population is obese, defined as having

CLARE Butler struggled with her weight for most of her adult life. As an emotional eater, food was her go-to whenever she felt sad, happy,

Plus, what to add to your grocery list this week

Researchers at the University of Toronto have found GLP-1 weight loss and diabetes drugs like Ozempic and Mounjaro double the risk of a severe form

FINISHING an eight-mile run, Tracy Hughes walks into her bathroom and turns on the shower. Wearing her form-fitting exercise kit, the mum-of-four has a svelte